Published in Cancer Sci on January 01, 2011
miRNAs in human cancer. J Pathol (2010) 6.02
MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci U S A (2011) 4.11
MicroRNAs in human cancer. Adv Exp Med Biol (2013) 3.19
The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease. Cell Death Differ (2013) 2.41
Molecular biology of lung cancer: clinical implications. Clin Chest Med (2011) 1.47
Functions of lncRNA HOTAIR in lung cancer. J Hematol Oncol (2014) 1.23
Increased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokers. Clin Cancer Res (2012) 1.18
TGFβR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness. Mol Cancer (2014) 1.15
miR-21, miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer. Br J Cancer (2012) 1.14
Regulation of microRNA expression and function by nuclear receptor signaling. Cell Biosci (2011) 1.12
Fractionated radiation alters oncomir and tumor suppressor miRNAs in human prostate cancer cells. Radiat Res (2012) 1.06
Expression profiling of difficult-to-diagnose thyroid histologic subtypes shows distinct expression profiles and identify candidate diagnostic microRNAs. Ann Surg Oncol (2011) 1.05
miR-19a: an effective regulator of SOCS3 and enhancer of JAK-STAT signalling. PLoS One (2013) 1.03
Mechanistic Roles of Noncoding RNAs in Lung Cancer Biology and Their Clinical Implications. Genet Res Int (2012) 1.03
Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC. Int J Oncol (2012) 1.00
MicroRNAs and lung cancers: from pathogenesis to clinical implications. Front Med (2012) 1.00
let-7 and miR-140 microRNAs coordinately regulate skeletal development. Proc Natl Acad Sci U S A (2013) 0.98
Differential miRNA expression profiles between the first and third trimester human placentas. Am J Physiol Endocrinol Metab (2013) 0.95
Increased expression of microRNA-17 predicts poor prognosis in human glioma. J Biomed Biotechnol (2012) 0.90
High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer. Oncotarget (2015) 0.90
High-throughput microRNA profiling of pediatric high-grade gliomas. Neuro Oncol (2013) 0.89
Tanshinones suppress AURKA through up-regulation of miR-32 expression in non-small cell lung cancer. Oncotarget (2015) 0.89
Comparative profiling of miRNA expression of lung adenocarcinoma cells in two-dimensional and three-dimensional cultures. Gene (2012) 0.87
MicroRNA in Human Glioma. Cancers (Basel) (2013) 0.87
Deregulation of serum microRNA expression is associated with cigarette smoking and lung cancer. Biomed Res Int (2014) 0.87
A Comprehensive Review of Dysregulated miRNAs Involved in Cervical Cancer. Curr Genomics (2014) 0.86
MicroRNAs as targets for dietary and pharmacological inhibitors of mutagenesis and carcinogenesis. Mutat Res (2012) 0.85
Integrative identification of deregulated miRNA/TF-mediated gene regulatory loops and networks in prostate cancer. PLoS One (2014) 0.85
Curcumin: updated molecular mechanisms and intervention targets in human lung cancer. Int J Mol Sci (2012) 0.85
Inhibition of proliferation of human lung cancer cells by green tea catechins is mediated by upregulation of let-7. Exp Ther Med (2012) 0.85
MicroRNA In Lung Cancer: Novel Biomarkers and Potential Tools for Treatment. J Clin Med (2016) 0.85
Influence of quercetin-rich food intake on microRNA expression in lung cancer tissues. Cancer Epidemiol Biomarkers Prev (2012) 0.84
Serum microRNA profiling to distinguish papillary thyroid cancer from benign thyroid masses. J Otolaryngol Head Neck Surg (2015) 0.84
MicroRNA miR-92a-1 biogenesis and mRNA targeting is modulated by a tertiary contact within the miR-17~92 microRNA cluster. Nucleic Acids Res (2014) 0.83
Stepwise assembly of multiple Lin28 proteins on the terminal loop of let-7 miRNA precursors. Nucleic Acids Res (2014) 0.83
Effect of cigarette smoke condensate on gene promoter methylation in human lung cells. Tob Induc Dis (2014) 0.82
Role of deregulated microRNAs in non-small cell lung cancer progression using fresh-frozen and formalin-fixed, paraffin-embedded samples. Oncol Lett (2015) 0.81
Clinical Significance of MicroRNA Expression Profiles and Polymorphisms in Lung Cancer Development and Management. Patholog Res Int (2011) 0.81
MicroRNA-206 inhibits the viability and migration of human lung adenocarcinoma cells partly by targeting MET. Oncol Lett (2016) 0.81
Reversible, interrelated mRNA and miRNA expression patterns in the transcriptome of Rasless fibroblasts: functional and mechanistic implications. BMC Genomics (2013) 0.80
Limited miR-17-92 overexpression drives hematologic malignancies. Leuk Res (2014) 0.80
Tumor surveillance by circulating microRNAs: a hypothesis. Cell Mol Life Sci (2014) 0.79
Differentially Expressed miRNAs in Tumor, Adjacent, and Normal Tissues of Lung Adenocarcinoma. Biomed Res Int (2016) 0.77
Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cells. J Clin Invest (2015) 0.77
Quantification of plasma microRNAs in a group of healthy smokers, ex-smokers and non-smokers and correlation to biomarkers of tobacco exposure. Biomarkers (2015) 0.77
Intracellular signals of lung cancer cells as possible therapeutic targets. Cancer Sci (2015) 0.77
miRNA Influences in NRF2 Pathway Interactions within Cancer Models. J Nucleic Acids (2015) 0.76
The roles of microRNAs and protein components of the microRNA pathway in lung development and diseases. Am J Respir Cell Mol Biol (2015) 0.76
Extracellular vesicles in smoking-related lung diseases. Oncotarget (2015) 0.75
Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer. J Exp Clin Cancer Res (2016) 0.75
Identification of Biomarker and Co-Regulatory Motifs in Lung Adenocarcinoma Based on Differential Interactions. PLoS One (2015) 0.75
MicroRNA biogenesis pathway genes polymorphisms and cancer risk: a systematic review and meta-analysis. PeerJ (2016) 0.75
miR-3941: a novel microRNA that controls IGBP1 expression and is associated with malignant progression of lung adenocarcinoma. Cancer Sci (2016) 0.75
Splicing regulator SLU7 preserves survival of hepatocellular carcinoma cells and other solid tumors via oncogenic miR-17-92 cluster expression. Oncogene (2016) 0.75
Combinations of elevated tissue miRNA-17-92 cluster expression and serum prostate-specific antigen as potential diagnostic biomarkers for prostate cancer. Oncol Lett (2017) 0.75
Friend leukemia virus integration 1 promotes tumorigenesis of small cell lung cancer cells by activating the miR-17-92 pathway. Oncotarget (2017) 0.75
Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest. Int J Oncol (2017) 0.75
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol (2011) 21.49
Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res (2004) 18.86
A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res (2005) 10.46
Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res (2004) 7.76
Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence. J Clin Oncol (2005) 5.63
Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci (2005) 4.55
Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst (2002) 3.44
let-7 regulates Dicer expression and constitutes a negative feedback loop. Carcinogenesis (2008) 2.75
Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1. Cancer Res (2007) 2.59
Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res (2005) 2.48
Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors. J Clin Oncol (2006) 2.37
TTF-1 expression in pulmonary adenocarcinomas. Am J Surg Pathol (2002) 2.32
MicroRNAs in biological processes and carcinogenesis. Carcinogenesis (2006) 2.14
Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster. Cancer Res (2008) 2.08
Diameter and rigidity of multiwalled carbon nanotubes are critical factors in mesothelial injury and carcinogenesis. Proc Natl Acad Sci U S A (2011) 2.01
Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J Infect Chemother (2010) 1.92
Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations. Nat Genet (2010) 1.90
Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction. J Clin Oncol (2004) 1.89
Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis. J Clin Oncol (2009) 1.78
Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth. Cancer Res (2007) 1.73
NKX2-1/TITF1/TTF-1-Induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinoma. Cancer Cell (2012) 1.68
Changes in colorectal cancer during a 20-year period: an extended report from the multi-institutional registry of large bowel cancer, Japan. Dis Colon Rectum (2003) 1.51
A rapid, sensitive assay to detect EGFR mutation in small biopsy specimens from lung cancer. J Mol Diagn (2006) 1.50
Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients. Int J Cancer (2004) 1.50
Stereoselective synthesis of oligo-alpha-(2,8)-sialic acids. J Am Chem Soc (2006) 1.48
ASH1 gene is a specific therapeutic target for lung cancers with neuroendocrine features. Cancer Res (2005) 1.45
Epidermal growth factor receptor gene amplification is acquired in association with tumor progression of EGFR-mutated lung cancer. Cancer Res (2008) 1.42
EGFR mutation is specific for terminal respiratory unit type adenocarcinoma. Am J Surg Pathol (2005) 1.42
Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at 21q11-21 in human lung cancer. Genes Chromosomes Cancer (2008) 1.41
Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients. Oncogene (2004) 1.41
Isolation of Helicobacter cinaedi from blood of an immunocompromised patient in Japan. J Infect Chemother (2003) 1.38
Bronchial casts and pandemic (H1N1) 2009 virus infection. Emerg Infect Dis (2010) 1.37
Expression of cancer/testis (CT) antigens in lung cancer. Lung Cancer (2003) 1.31
Roles of achaete-scute homologue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancer. Cancer Res (2008) 1.30
A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer. J Natl Cancer Inst (2007) 1.30
Chromosome instability in human lung cancers: possible underlying mechanisms and potential consequences in the pathogenesis. Oncogene (2002) 1.29
Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers. Oncogene (2002) 1.29
Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. Oncogene (2002) 1.28
Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers. Oncogene (2002) 1.28
Expression profiling of genes regulated by TGF-beta: differential regulation in normal and tumour cells. BMC Genomics (2007) 1.25
Down-regulation of DUSP6 expression in lung cancer: its mechanism and potential role in carcinogenesis. Am J Pathol (2009) 1.24
Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis. Cancer Res (2012) 1.23
NKX2-1/TTF-1: an enigmatic oncogene that functions as a double-edged sword for cancer cell survival and progression. Cancer Cell (2013) 1.22
Traditional chinese medicine for chronic fatigue syndrome. Evid Based Complement Alternat Med (2008) 1.19
Significant up-regulation of a novel gene, CLCP1, in a highly metastatic lung cancer subline as well as in lung cancers in vivo. Oncogene (2002) 1.19
Measurement of in vivo local shear modulus using MR elastography multiple-phase patchwork offsets. IEEE Trans Biomed Eng (2003) 1.18
Clinically relevant characterization of lung adenocarcinoma subtypes based on cellular pathways: an international validation study. PLoS One (2010) 1.18
Nongenomic beta estrogen receptors enhance beta1 adrenergic signaling induced by the nicotine-derived carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human small airway epithelial cells. Cancer Res (2007) 1.18
Association between mitotic spindle checkpoint impairment and susceptibility to the induction of apoptosis by anti-microtubule agents in human lung cancers. Am J Pathol (2003) 1.17
MYBPH, a transcriptional target of TTF-1, inhibits ROCK1, and reduces cell motility and metastasis. EMBO J (2011) 1.17
Interleukin-6 and cardiovascular diseases. Jpn Heart J (2004) 1.14
Neurotensin receptor 1 determines the outcome of non-small cell lung cancer. Clin Cancer Res (2010) 1.14
Identification of decatenation G2 checkpoint impairment independently of DNA damage G2 checkpoint in human lung cancer cell lines. Cancer Res (2004) 1.13
Homozygous deletion of CDKN2A/2B is a hallmark of iron-induced high-grade rat mesothelioma. Lab Invest (2010) 1.12
hDREF regulates cell proliferation and expression of ribosomal protein genes. Mol Cell Biol (2007) 1.12
Silent information regulator, Sirtuin 1, and age-related diseases. Geriatr Gerontol Int (2009) 1.12
miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer. Cancer Res (2011) 1.10
One-pot synthesis of sialo-containing glycosyl amino acids by use of an N-trichloroethoxycarbonyl-beta-thiophenyl sialoside. Chemistry (2005) 1.10
K-ras gene mutation enhances motility of immortalized airway cells and lung adenocarcinoma cells via Akt activation: possible contribution to non-invasive expansion of lung adenocarcinoma. Am J Pathol (2004) 1.10
Cell cycle activation in lung adenocarcinoma cells by the ErbB3/phosphatidylinositol 3-kinase/Akt pathway. Carcinogenesis (2003) 1.09
Direct evidence for the dirac-cone topological surface states in the ternary chalcogenide TlBiSe₂. Phys Rev Lett (2010) 1.09
A formal total synthesis of taxol aided by an automated synthesizer. Chem Asian J (2006) 1.08
Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells. Eur J Pharmacol (2010) 1.08
Iron overload signature in chrysotile-induced malignant mesothelioma. J Pathol (2012) 1.08
Concern Differential inactivation of caspase-8 in lung cancers. Cancer Biol Ther (2002) 1.07
Endogenous angiogenesis inhibitor vasohibin1 exhibits broad-spectrum antilymphangiogenic activity and suppresses lymph node metastasis. Am J Pathol (2010) 1.06
Significant growth inhibition of human lung cancer cells both in vitro and in vivo by the combined use of a selective cyclooxygenase 2 inhibitor, JTE-522, and conventional anticancer agents. Clin Cancer Res (2002) 1.06
Tetraspanin CD151 regulates transforming growth factor beta signaling: implication in tumor metastasis. Cancer Res (2010) 1.04
Maspin expression in normal lung and non-small-cell lung cancers: cellular property-associated expression under the control of promoter DNA methylation. Oncogene (2004) 1.02
Outbreak of human metapneumovirus infection in elderly inpatients in Japan. J Am Geriatr Soc (2006) 1.01
Fenton reaction induced cancer in wild type rats recapitulates genomic alterations observed in human cancer. PLoS One (2012) 1.00
A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers. Am J Pathol (2002) 1.00
Expression of CD109 in human cancer. Oncogene (2004) 1.00
Expression of chromobox homolog 7 (CBX7) is associated with poor prognosis in ovarian clear cell adenocarcinoma via TRAIL-induced apoptotic pathway regulation. Int J Cancer (2014) 0.99
Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo. Fundam Clin Pharmacol (2012) 0.99
Peculiar Rashba splitting originating from the two-dimensional symmetry of the surface. Phys Rev Lett (2009) 0.99
Direct and stereoselective synthesis of beta-linked 2,6-deoxyoligosaccharides. Angew Chem Int Ed Engl (2007) 0.99
Acupuncture regulates leukocyte subpopulations in human peripheral blood. Evid Based Complement Alternat Med (2007) 0.98
LKB1 gene mutations in Japanese lung cancer patients. Cancer Sci (2007) 0.98
Differential toxicogenomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin in malignant and nonmalignant human airway epithelial cells. Toxicol Sci (2002) 0.97
Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer. Int J Cancer (2003) 0.97
β-galactosyl Yariv reagent binds to the β-1,3-galactan of arabinogalactan proteins. Plant Physiol (2013) 0.97
Acute disseminated encephalomyelitis following Plasmodium vivax malaria. J Infect Chemother (2003) 0.96
Synthesis of di-branched heptasaccharide by one-pot glycosylation using seven independent building blocks. Org Lett (2002) 0.96
Down-regulation of SKP2 induces apoptosis in lung-cancer cells. Cancer Sci (2003) 0.96
Continuous-flow synthesis of vitamin D3. Chem Commun (Camb) (2010) 0.96
Stereoselective Synthesis of alpha(2,9) Di- to Tetrasialic Acids, Using a 5,4-N,O-Carbonyl Protected Thiosialoside. J Org Chem (2009) 0.95
CK20 expression, CDX2 expression, K-ras mutation, and goblet cell morphology in a subset of lung adenocarcinomas. J Pathol (2004) 0.95
Efficient stereoselective synthesis of gamma-N-glycosyl asparagines by N-glycosylation of primary amide groups. J Am Chem Soc (2005) 0.94
Relationship of deregulated signaling converging onto mTOR with prognosis and classification of lung adenocarcinoma shown by two independent in silico analyses. Cancer Res (2009) 0.94
Roles of POLD4, smallest subunit of DNA polymerase delta, in nuclear structures and genomic stability of human cells. Biochem Biophys Res Commun (2009) 0.94
Total synthesis of (R)-telomestatin. Org Lett (2006) 0.94
Growth regulation via insulin-like growth factor binding protein-4 and -2 in association with mutant K-ras in lung epithelia. Am J Pathol (2006) 0.93
Total synthesis of spiruchostatin B aided by an automated synthesizer. Org Biomol Chem (2011) 0.93
Aberrant methylation of the cyclin D2 promoter in primary small cell, nonsmall cell lung and breast cancers. Int J Cancer (2003) 0.93
A flavonoid from Brassica rapa flower as the UV-absorbing nectar guide. Phytochemistry (2002) 0.93
A new mechanism of methotrexate action revealed by target screening with affinity beads. Mol Pharmacol (2006) 0.93
The Epstein-Barr virus latent membrane protein 1 and transforming growth factor--β1 synergistically induce epithelial--mesenchymal transition in lung epithelial cells. Am J Respir Cell Mol Biol (2010) 0.92
Resveratrol improves hippocampal atrophy in chronic fatigue mice by enhancing neurogenesis and inhibiting apoptosis of granular cells. Biol Pharm Bull (2011) 0.92
Anti-influenza virus compound from Streptomyces sp. RI18. Org Lett (2010) 0.92